STRENGTHENING EVIDENCE THROUGH HEALTH RESEARCH WHERE MOST PEOPLE ACCESS HEALTHCARE, RACGP joins consortium and calls for practice-based research network in primary health
With
Dr Michael Wright GP, President
The Royal Australian College of General Practitioners (RACGP) &
Associate Professor,
International Centre for Future Health Systems (ICFHS)
Australian Health Journal segment
Filmed in Sydney | March 2025
In February 2025, the Australian Government committed over $22 million for primary care research, including $5.2m awarded to Professor Michael Kidd, Director of the International Centre for Future Health Systems at UNSW and recently appointed Australia’s Chief Medical Officer, to lead the establishment of one of the largest research collaborations in Australia focused on improving primary care.
The Royal Australian College of GPs says a new national multidisciplinary consortium for primary care research is a positive step forward to improve patient care.
The RACGP is a member of the National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium, which involves 100 primary care researchers from 20 universities from across the country.
RACGP President Dr Michael Wright said: “Every year more than 22 million Australians see a specialist GP for their essential health care, making general practice is the most accessed part of our health system.
“Yet research in general practice is vastly underrepresented and underfunded. General practice receives less than 2% of our national medical research funding.
“This new consortium is an important and exciting opportunity to design, test and innovate models of care to better meet the needs of patients across Australia, and I’m proud the RACGP is a member.
“The RACGP is calling for all political parties to commit to funding a national practice-based research network, like they have in Canada and the United Kingdom.
“These networks have proven to be immensely valuable overseas.
“We’re also calling for funding to test how multidisciplinary practice teams work at full scope in Australia, in order to improve access to care for patients.
“We know people get the best outcomes when their GP works together with their other specialists, and health professionals, and it’s especially valuable for people with chronic and complex illnesses.
Source: Highlights from RACGP media release
-
New Generative AI and machine learning frontier on unused patient care data
Drawing from GE’s 125-year legacy in healthcare, Amit Yadav, CEO GE HealthCare ANZ is leading efforts to integrate AI into medical imaging devices and optimise workflow efficiencies. He stresses the importance of leveraging the vast amount of untapped healthcare data, with an emphasis on automating manual processes to enhance productivity. Additionally, his focus extends to utilising AI for workflow optimisation and ensuring compliance with local regulations and standards to prioritise safety.
-
Australian Teletrial Program reaches significant milestones in trials and participants
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements.
-
Significant funding announced for NSW biomedical researchers
The Snow Medical Research Foundation (Snow Medical) has announced a new $24 million investment in three outstanding Australian biomedical researchers through its prestigious Snow Fellowships.
These Fellows will tackle major global health challenges spanning autoimmune disease, neurological disorders, and genetic disease. Their work addresses conditions that disproportionately affect vulnerable and underserved populations, including First Nations communities, while advancing precision medicine and translational care. Collectively, their research aims to deliver safer vaccines, better diagnostics, and more equitable genomic and neurological healthcare.
